News
The Worshipful Company of Spectacle Makers awards two Master’s Medals for early career research
The Worshipful Company of Spectacle Makers (WCSM) this week announced the winners of two Master’s Medals for 2025. Fabian Yii from Edinburgh was awarded the Master’s Medal for his paper, 'Fundus Refraction Offset as a Personalized Biomarker for 12-Year Risk...
NICE approves treatment for cause of sudden sight loss
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...
Researchers identify a novel genetic cause of Fuchs endothelial corneal dystrophy
Researchers identify a novel genetic cause of Fuchs endothelial corneal dystrophy, offering new ways for future therapies to target this common, age-related cause of visual loss. In a landmark study, researchers supported by NIHR Moorfields Biomedical Research Centre, have identified...
Register: UK Eye Genetics Group (UK-EGG) Annual Conference 2025
Save the Date – Register NOW – Call for Abstracts... This year, the meeting will be chaired by Professor Susan Downes and by Miss Samantha De Silva and hosted at St Anne’s College, in Oxford! The day will include thought...
On Retina UK's behalf... Grant Call - Application Deadline Extension
Further to their letter of November 2024, Retina UK is extending the deadline for expressions of interest / preliminary applications to their first grant call for an award of up to £1 million. The call forms a key element of...
Large-scale study uncovers demographic and sex factors behind genetic cause of age-related visual loss
A new study has identified a major genetic contributor to Fuchs’ Endothelial Corneal Dystrophy (FECD), a common cause of vision loss, also highlighting the significant roles of sex and ancestry. FECD is a common, inherited eye condition that primarily affects...
Genetic therapy gives infants life-changing improvements in sight
Four young children have gained life-changing improvements in sight following treatment with a pioneering new genetic medicine through Moorfields Eye Hospital and UCL Institute of Ophthalmology, with the support of MeiraGTx. The children were born with a severe impairment to...
Age and gender impacts effectiveness of new gene therapy treatments for eye diseases, new study finds
Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular Therapy, reveal how age and gender affects inflammation caused by gene...
UK-EGG Seedcorn award call now open
The UK Eye Genetics Group is now accepting applications for a new Seedcorn Award, offering up to £5,000, to support early career researchers in conducting innovative projects focused on the diagnosis, understanding, prevention, management and treatment of genetic eye diseases....
New study uncovers key mechanism behind a common genetic cause of age-related visual loss
A groundbreaking study has revealed important insights into the mechanisms behind Fuchs Endothelial Corneal Dystrophy (FECD), a common cause of age-related visual loss, providing hope for future therapeutic developments, and finding implications for other neurological diseases. FECD is a common,...
